Latest Astellas Pharma US Inc. Stories
DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- On January 1, 2011, the Donate Life float will roll through the streets of Pasadena reminding millions of viewers of the Rose ParadeÂ® to "Seize the Day" and register as organ donors in an effort to save lives.
MORRISTOWN, N.J., July 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.
CHICAGO, June 7 /PRNewswire/ -- If an average day begins as a hectic race to get the kids off to school and get to work on time, imagine starting that day with a migraine.
TOKYO and MELVILLE, N.Y. May 16 /PRNewswire-FirstCall/ -- Astellas Pharma Inc. (TSE: 4503), a global pharmaceutical company, and OSI Pharmaceuticals, Inc.
DEERFIELD, Ill., May 3 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the launch of "Science WoRx," a program designed to help science teachers inspire the next generation of scientists.
TOKYO, April 23 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc.
SAN FRANCISCO and TOKYO, April 14 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma Inc.
RICHMOND, Va., April 5 /PRNewswire/ -- According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths.
According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths.
TOKYO, March 2 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.
- Large; stout; burly.